Cogent Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 6 | -$0.56 | -$0.56 | -$0.56 |
| Q2 2024 | 2 | -$0.57 | -$0.57 | -$0.57 |
| Q3 2024 | 7 | -$0.67 | -$0.51 | -$0.59 |
| Q1 2025 | 3 | -$0.63 | -$0.48 | -$0.58 |
| Q2 2025 | 2 | -$0.57 | -$0.57 | -$0.57 |
| Q3 2025 | 2 | -$0.54 | -$0.54 | -$0.54 |
| Q4 2025 | 2 | -$0.53 | -$0.53 | -$0.53 |
Cogent Biosciences, Inc. Earnings Date And Information
Cogent Biosciences, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.64 earnings per share for the quarter, missing analysts' consensus estimates of $-0.55 by $0.09. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cogent Biosciences, Inc. has generated $-2 earnings per share over the last year ($-2.42 diluted earnings per share) and currently has a price-to-earnings ratio of -4.15. Cogent Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based on prior year's report dates.
Cogent Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.55 | -$0.64 | -0.09 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.55 | -$0.59 | -0.04 | $0 | $0 |
| 05/07/2024 | Q1 2024 | -$0.50 | -$0.62 | -0.12 | $0 | |
| 02/26/2024 | Q4 2023 | -$0.54 | -$0.63 | -0.09 | $5.59 M | |
| 11/07/2023 | Q3 2023 | -$0.64 | $0 | |||
| 08/08/2023 | Q2 2023 | -$0.53 | -$0.59 | -0.06 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.58 | -$0.48 | 0.1 | $0 | |
| 03/14/2023 | Q4 2022 | -$0.50 | -$0.50 | 0 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.51 | -$0.48 | 0.03 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.64 | -$0.71 | -0.07 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.53 | -$0.66 | -0.13 | $0 | |
| 03/15/2022 | Q4 2021 | -$0.55 | -$0.57 | -0.02 | $0 | |
| 11/10/2021 | Q3 2021 | -$0.43 | -$0.48 | -0.05 | $0 | |
| 08/16/2021 | Q2 2021 | -$0.39 | -$0.43 | -0.04 | $0 | |
| 05/12/2021 | Q1 2021 | -$0.46 | -$0.34 | 0.12 | $0 | |
| 03/16/2021 | Q4 2020 | -$0.30 | -$0.59 | -0.29 | $0 | |
| 11/09/2020 | Q3 2020 | -$0.76 | -$5.07 | -4.31 | $312,000 | |
| 08/11/2020 | Q2 2020 | -$0.84 | -$0.95 | -0.11 | $528,000 | |
| 05/11/2020 | Q1 2020 | -$1.23 | -$0.81 | 0.42 | $7.03 M | |
| 03/26/2020 | Q4 2019 | -$1.14 | $0.28 | 1.42 | $15.29 M |
Cogent Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Cogent Biosciences, Inc.'s earnings date?
Cogent Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based off last year's report dates.
-
How can I listen to Cogent Biosciences, Inc.'s earnings conference call?
The conference call for Cogent Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Cogent Biosciences, Inc.'s conference call transcript?
The conference call transcript for Cogent Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Cogent Biosciences, Inc. generate each year?
Cogent Biosciences, Inc. (:COGT) has a recorded net income of $0. Cogent Biosciences, Inc. has generated $-2.42 earnings per share over the last four quarters.
-
What is Cogent Biosciences, Inc.'s price-to-earnings ratio?
Cogent Biosciences, Inc. (:COGT) has a price-to-earnings ratio of -4.15 and price/earnings-to-growth ratio is -0.04.
